Circulating tumor nucleic acids: Perspective in breast cancer

Breast Care

Volumn 5, Issue 2, 2010, Pages 75-80

  Casciano, Ida ^a   Di Vinci, Angela ^a   Banelli, Barbara ^a   Brigati, Claudio ^a   Forlani, Alessandra ^a   Allemanni, Giorgio ^a   Romani, Massimo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Biomarker; Breast cancer; Circulating nucleic acids; Molecular biology

Indexed keywords

APC PROTEIN; DEATH ASSOCIATED PROTEIN KINASE; DNA; NUCLEIC ACID; PROTEIN P53; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

BREAST CANCER; CARCINOGENESIS; CHROMATIN; CODON; EARLY DIAGNOSIS; EPIGENETICS; EXON; GEL ELECTROPHORESIS; GENE EXPRESSION PROFILING; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PURIFICATION; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 77952866747     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000310113     Document Type: Review

References (44)

1. Mandel PM: Les acides nucleiques du plasma sanguin chez l'homme. CR Acad Sci Paris 1940;142: 241-253.
2. Tan EM, Schur PH, Carr RI, Kunkel HG: Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 1966;45:1732-1740.
3. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ: Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977;37:646-650.
4. Sorenson GD, Pribish DM, Valone FH, Memoli VA, Bzik DJ, Yao SL: Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol Biomarkers Prev 1994; 3:67-71.
5. Kopreski MS, Benko FA, Kwak LW, Gocke CD: Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 1999;5:1961-1965.
6. Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, Roz E, Cirenei N, Bellomi M, Pelosi G, Pierotti MA, Pastorino U: Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003;21:3902-3908.
7. Yam LT, Janckila AJ: Immunocytodiagnosis of carcinocythemia in disseminated breast cancer. Acta Cytol 1987;31:68-72.
8. Chen X, Bonnefoi H, Diebold-Berger S, Lyautey J, Lederrey C, Faltin-Traub E, Stroun M, Anker P: Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin Cancer Res 1999;5:2297-2303.
9. Shapiro B, Chakrabarty M, Cohn EM, Leon SA: Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer 1983;51:2116-2120.
10. Giacona MB, Ruben GC, Iczkowski KA, Roos TB, Porter DM, Sorenson GD: Cell-free DNA in human blood plasma: Length measurements in patients with pancreatic cancer and healthy controls. Pancreas 1998;17:89-97.
11. Koffler D, Agnello V, Winchester R, Kunkel HG: The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. J Clin Invest 1973;52:198-204.
12. Leon SA, Revach M, Ehrlich GE, Adler R, Petersen V, Shapiro B: DNA in synovial fluid and the circulation of patients with arthritis. Arthritis Rheum 1981;24:1142-1150.
13. Atamaniuk J, Vidotto C, Tschan H, Bachl N, Stuhlmeier KM, Muller MM: Increased concentrations of cell-free plasma DNA after exhaustive exercise. Clin Chem 2004;50:1668-1670.
14. Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA: Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000;46:319-323.
15. Swarup V, Rajeswari MR: Circulating (cell-free) nucleic acids--a promising, non-invasive tool for early detection of several human diseases. FEBS Lett 2007;581:795-799.
16. Hodgson DR, Wellings R, Orr MC, McCormack R, Malone M, Board RE, Cantarini MV: Circulating tumour-derived predictive biomarkers in oncology. Drug Discov Today 2010;15:98-101.
17. Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, Martino S, Hoon DS: Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol 2006;24: 4270-4276.
18. Ng EK, Tsui NB, Lam NY, Chiu RW, Yu SC, Wong SC, Lo ES, Rainer TH, Johnson PJ, Lo YM: Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem 2002;48:1212-1217.
19. Xue X, Teare MD, Holen I, Zhu YM, Woll PJ: Optimizing the yield and utility of circulating cellfree DNA from plasma and serum. Clin Chim Acta 2009;404:100-104.
20. Chan KC, Yeung SW, Lui WB, Rainer TH, Lo YM: Effects of preanalytical factors on the molecular size of cell-free DNA in blood. Clin Chem 2005;51: 781-784.
21. Sozzi G, Roz L, Conte D, Mariani L, Andriani F, Verderio P, Pastorino U: Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays. J Natl Cancer Inst 2005;97:1848-1850.
22. Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Tunnacliffe A: Degenerate oligonucleotide- primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 1992;13:718-725.
23. Di Vinci A, Gelvi I, Banelli B, Casciano I, Allemanni G, Romani M: Meth-DOP-PCR: an assay for the methylation profiling of trace amounts of DNA extracted from bodily fluids. Lab Invest 2006; 86:297-303.
24. Fleischhacker M, Schmidt B: Circulating nucleic acids (CANs) and cancer - a survey. Biochim Biophys Acta 2007;1775:181-232.
25. Catarino R, Ferreira MM, Rodrigues H, Coelho A, Nogal A, Sousa A, Medeiros R: Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer. DNA Cell Biol 2008;27:415-421.
26. Kohler C, Radpour R, Barekati Z, Asadollahi R, Bitzer J, Wight E, Burki N, Diesch C, Holzgreve W, Zhong XY: Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors. Mol Cancer 2009;8:105.
27. Gormally E, Vineis P, Matullo G, Veglia F, Caboux E, Le Roux E, Peluso M, Garte S, Guarrera S, Munnia A, Airoldi L, Autrup H, Malaveille C, Dunning A, Overvad K, Tjonneland A, Lund E, Clavel-Chapelon F, Boeing H, Trichopoulou A, Palli D, Krogh V, Tumino R, Panico S, Buenode- Mesquita HB, Peeters PH, Pera G, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quiros JR, Hallmans G, Day NE, Key TJ, Saracci R, Kaaks R, Riboli E, Hainaut P: Tp53 and kras2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study. Cancer Res 2006;66:6871-6876.
28. Di GH, Liu G, Wu J, Shen ZZ, Shao ZM: (Peripheral blood mutated p53 DNA and its clinical value in human breast cancer). Zhonghua Zhong Liu Za Zhi 2003;25:137-140.
29. Silva JM, Dominguez G, Garcia JM, Gonzalez R, Villanueva MJ, Navarro F, Provencio M, San Martin S, Espana P, Bonilla F: Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations. Cancer Res 1999;59:3251-3256. (Pubitemid 29316030)
30. Silva JM, Garcia JM, Dominguez G, Silva J, Miralles C, Cantos B, Coca S, Provencio M, Espana P, Bonilla F: Persistence of tumor DNA in plasma of breast cancer patients after mastectomy. Ann Surg Oncol 2002;9:71-76.
31. Garcia JM, Garcia V, Silva J, Pena C, Dominguez G, Sanchez A, Sanfrutos L, Provencio M, Millan I, Chaparro D, Espana P, Bonilla F: Extracellular tumor DNA in plasma and overall survival in breast cancer patients. Genes Chromosomes Cancer 2006;45:692-701.
32. Banelli B, Casciano I, Di Vinci A, Gatteschi B, Levaggi A, Carli F, Bighin C, Salvi S, Allemanni G, Ghiorzo P, Pronzato P, Venturini M, Romani M, Del Mastro L: Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer. Ann Oncol 2009; Epub ahead of print.
33. Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, Lederrey C, Anker P: Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996;2:1033-1035. (Pubitemid 26306844)
34. Dehan P, Kustermans G, Guenin S, Horion J, Boniver J, Delvenne P: DNA methylation and cancer diagnosis: New methods and applications. Expert Rev Mol Diagn 2009;9:651-657.
35. Dulaimi E, Hillinck J, Ibanez de Caceres I, Al- Saleem T, Cairns P: Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res 2004;10:6189-6193. (Pubitemid 39287525)
36. Di Vinci A, Perdelli L, Banelli B, Salvi S, Casciano I, Gelvi I, Allemanni G, Margallo E, Gatteschi B, Romani M: P16(ink4a) promoter methylation and protein expression in breast fibroadenoma and carcinoma. Int J Cancer 2005;114:414-421. (Pubitemid 40279962)
37. McCulloch RK, Sellner LN, Papadimitrou JM, Turbett GR: The incidence of microsatellite instability and loss of heterozygosity in fibroadenoma of the breast. Breast Cancer Res Treat 1998;49:165-169.
38. Martinez-Galan J, Torres B, Del Moral R, Munoz- Gamez JA, Martin-Oliva D, Villalobos M, Nunez MI, Luna Jde D, Oliver FJ, Ruiz de Almodovar JM: Quantitative detection of methylated ESR1 and 14-3-3-sigma gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy. Cancer Biol Ther 2008;7:958-965.
39. Chen XQ, Bonnefoi H, Pelte MF, Lyautey J, Lederrey C, Movarekhi S, Schaeffer P, Mulcahy HE, Meyer P, Stroun M, Anker P: Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 2000;6:3823-3826.
40. Gal S, Fidler C, Lo YM, Chin K, Moore J, Harris AL, Wainscoat JS: Detection of mammaglobin mRNA in the plasma of breast cancer patients. Ann N Y Acad Sci 2001;945:192-194.
41. Silva JM, Dominguez G, Silva J, Garcia JM, Sanchez A, Rodriguez O, Provencio M, Espana P, Bonilla F: Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res 2001;7:2821-2825.
42. Heneghan HM, Miller, N., Lowery, A.J., Sweeney, K.J., Kerin, M.J.: MicroRNAs as novel biomarkers for breast cancer. J Oncol 2009; Epub ahead of print.
43. Huang ZH, Li LH, Hua D: Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients. Cancer Lett 2006;243:64-70.
44. Fiegl H, Millinger S, Mueller-Holzner E, Marth C, Ensinger C, Berger A, Klocker H, Goebel G, Widschwendter M: Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. Cancer Res 2005;65: 1141-1145.